US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

102.50

-0.7073-0.69%

Post-market: 102.36-0.1428-0.14%19:30 EDT

Volume:18.72K

Turnover:1.92M

Market Cap:128.12M

PE:- -

High:103.87

Open:103.87

Low:102.00

Close:103.21

52wk High:110.05

52wk Low:70.27

Shares:1.25M

Float Shares:1.25M

Volume Ratio:1.09

T/O Rate:1.50%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1

Kevin Warsh has little to say about interest rates. But he has plenty to say about AI

Radiopharm Theranostics Lifts Cap on Securities Purchase Plan to AUD10 Million

Actinogen Medical Seeks ASX Quotation for 3.5 Million Incentive Shares

Circio Strengthens Board With RNA Therapy Veterans Ahead of Clinical Push

Fed's Paulson says she keeps an 'open mind' on interest rates

Maria Eloisa Capurro / Bloomberg

Eikon Therapeutics Announces Recent Board Director Resignations

Fresenius announces FDA approval of rituximab biosimilar

Radiopharm Theranostics Seeks ASX Quotation for Major Share Issuance

Nanobiotix Updates Share Capital and Voting Rights as of June 30, 2026

Fed officials warn not raising interest rates was a mistake

Supply constraints, not falling interest rates, to drive property returns: Hines

Gerine Tang Yi Qian

Biophytis Publishes 2025 Accounts as Trading Resumes Amid Going-Concern Doubts

High interest rates and low confidence put construction firms under pressure, Lords warns

BOE More Likely to Cut Rates than Raise Them

Bank of England holds interest rates but warns of rises to come

FTSE 100 Live: Stocks to fall after Trump warns Iran ‘beating’; Bank to hold interest rates

JNJ enters strategic agreement to acquire Sail Biomedicines for $2.58B

Alvotech announces successful closure of FDA inspection of manufacturing facility

Viatris receives FDA approval for Gwyn Lo contraceptive patch

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BBP/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":102.4978,"timestamp":1790971200000,"preClose":103.2051,"halted":0,"volume":18715,"hourTrading":{"tag":"盘后","latestPrice":102.355,"preClose":102.4978,"latestTime":"19:30 EDT","volume":12,"amount":1229.9736,"timestamp":1790983804639,"change":-0.1428,"changeRate":-0.001393,"amplitude":0},"delay":0,"changeRate":-0.0068533434878703045,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"Market Closed","change":-0.7073,"latestTime":"10-02 16:00:00 EDT","open":103.87,"high":103.87,"low":102.0005,"amount":1918982.2008,"amplitude":0.018114,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.2051,"sharesOutstanding":600004,"nav":102.494,"aum":128117601.53,"bidAskSpread":0.002439,"postHourTrading":{"tag":"盘后","latestPrice":102.355,"preClose":102.4978,"latestTime":"19:30 EDT","volume":12,"amount":1229.9736,"timestamp":1790983804639,"change":-0.1428,"changeRate":-0.001393,"amplitude":0},"volumeRatio":1.0888030521127026,"impliedVol":0.2277,"impliedVolPercentile":0.4462},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0888030521127026,"shares":1250004,"dividePrice":0,"high":103.87,"amplitude":0.018114,"preClose":103.2051,"low":102.0005,"week52Low":70.27,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":102.4978,"eps":0,"divideRate":0,"volume":18715,"delay":0,"ttmEps":0,"open":103.87,"prevYearClose":79.9149,"prevWeekClose":104.6582,"prevMonthClose":105.5872,"prevQuarterClose":105.5872,"fiveDayClose":104.6582,"twentyDayClose":108.8566,"sixtyDayClose":103.6198},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657572786","title":"Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2657572786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657572786?lang=en_us&edition=fundamental","pubTime":"2026-08-06 07:25","pubTimestamp":1785972320,"startTime":"0","endTime":"0","summary":"The latest update is out from Takeda Pharmaceutical Co ( ($JP:4502) ). Takeda has secured U.S. FDA approval for ORZEYFUL, an oral orexin receptor 2...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-first-in-class-u-s-approval-for-orexin-therapy-in-narcolepsy-type-1?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-first-in-class-u-s-approval-for-orexin-therapy-in-narcolepsy-type-1?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECB","RSPH","TBXU","PSCH","IEIH","IDNA","BBP","SYNB","BMED","GDOC","NVIB","LABU","MRNX","IYH","IBB","BK4585","LFSC","XLVX","BK4588","MEDI","FRTY","PINK","GNMX","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657543270","title":"Kevin Warsh has little to say about interest rates. But he has plenty to say about AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2657543270","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657543270?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:30","pubTimestamp":1785925825,"startTime":"0","endTime":"0","summary":"Federal Reserve Chairman Kevin Warsh has been outspoken about AI and its potential economic benefits. His view on where interest rates are heading, however, is harder to pin down.In the nine weeks since taking the helm at America’s central bank, Warsh has declined to publicly discuss what recent economic trends mean for rates, abandoning the long-held practice of providing “forward guidance.” He reinforced that approach last week after the Fed’s latest decision to hold its benchmark lending rate steady for the fifth consecutive time, saying it’s been “a change for the better.”Warsh has been much more forthcoming about AI. He said robust business investment, much of it driven by demand for AI infrastructure, “is preparing the ground for future growth.” He has also argued that AI could boost productivity and even lower inflation, which would give the Fed room to cut rates.When asked during last month’s congressional hearing if AI gives the Fed an opportunity to cut rates, Warsh said: “I ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cnn_highlight","url":"https://edition.cnn.com/2026/08/05/economy/kevin-warsh-fed-inflation-ai","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2026/08/05/economy/kevin-warsh-fed-inflation-ai","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["TSLP","VGLT","VGSH","GOVT","HYG","AVSD","VGIT","BBP","FXL","MUB","TMF","SCHO","SHV","ARTY","IEI","PEVC","BOXX","SHY","AGIX","KBE","SKRE","AIPO","LQD","BND","QTOC","CAOS","FXR","UUP","RJZ","VAW","VTHR","CGDV","EDV","IJK","IMF","KOMP","MINT","CHAT","UCC","LRCY","TLTW","TBT","FAZ","DFUV","UBT","BIL","ANEW","UDN","AGG","CLIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657924265","title":"Radiopharm Theranostics Lifts Cap on Securities Purchase Plan to AUD10 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657924265","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657924265?lang=en_us&edition=fundamental","pubTime":"2026-08-05 12:02","pubTimestamp":1785902537,"startTime":"0","endTime":"0","summary":"The latest update is out from Radiopharm Theranostics Limited ( ($AU:RAD) ). Radiopharm Theranostics Limited, an ASX-listed biotechnology company s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/radiopharm-theranostics-lifts-cap-on-securities-purchase-plan-to-aud10-million?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/radiopharm-theranostics-lifts-cap-on-securities-purchase-plan-to-aud10-million?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","BK4585","FWD","BK4588","XT","LNGR","JDOC","SYNB","IEIH","FHLC","RSPH","IBB","BBP","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657217591","title":"Actinogen Medical Seeks ASX Quotation for 3.5 Million Incentive Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2657217591","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657217591?lang=en_us&edition=fundamental","pubTime":"2026-08-05 10:57","pubTimestamp":1785898667,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has issued an announcement. Actinogen Medical Limited, an ASX-listed biotechnology company trading under the ticker...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-3-5-million-incentive-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-3-5-million-incentive-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","AGNG","IEIH","SYNB","FWD","BK4585","JDOC","FHLC","BBP","LNGR","BK4588","XT","RSPH","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656508531","title":"Circio Strengthens Board With RNA Therapy Veterans Ahead of Clinical Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2656508531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656508531?lang=en_us&edition=fundamental","pubTime":"2026-08-04 17:32","pubTimestamp":1785835946,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA is a biotechnology developer of circular RNA-based gene express...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-strengthens-board-with-rna-therapy-veterans-ahead-of-clinical-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-strengthens-board-with-rna-therapy-veterans-ahead-of-clinical-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","SYNB","DARP","IBB","IEIH","BK4585","FHLC","RNA","AGNG","XT","BK4139","BK4588","IE0009354923.USD","JDOC","RSPH","BBP","BK4505","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657952235","title":"Fed's Paulson says she keeps an 'open mind' on interest rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657952235","media":"Maria Eloisa Capurro / Bloomberg","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657952235?lang=en_us&edition=fundamental","pubTime":"2026-08-04 12:46","pubTimestamp":1785818782,"startTime":"0","endTime":"0","summary":"Federal Reserve Bank of Philadelphia president Anna Paulson said she will keep an open mind about the path for interest rates, focusing on the trends of underlying inflation.\n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/us-economy/feds-paulson-says-she-keeps-open-mind-interest-rates?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/us-economy/feds-paulson-says-she-keeps-open-mind-interest-rates?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["BOND","VGSH","UBT","VGLT","TLH","UDN","TLTW","BND","EDV","CLIX","DBND","GOVT","TBT","AGG","TIP","PBDC","AVSD","TYO","VCIT","GOLY","TMF","BBP","FAZ","JPST","USHY","SHY","MUB","CAOS","VCSH","SCHO","FXL","CGDV","KBE","ANEW","BSV","GBIL","IEI","LQD","MINT","BIL","NGHT","DFUV","SHV","TBIL","UUP","SKRE","BOXX","VGIT","ZROZ","HYG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300172","title":"Eikon Therapeutics Announces Recent Board Director Resignations","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300172","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300172?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:32","pubTimestamp":1785796348,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics, Inc. ( ($EIKN) ) has provided an announcement. On July 31, 2026, Eikon Therapeutics, Inc., a biotechnology company focused on d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eikon-therapeutics-announces-recent-board-director-resignations?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eikon-therapeutics-announces-recent-board-director-resignations?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","JDOC","BK4139","BBP","LNGR","FHLC","EIKN","IBB","AGNG","BK4585","XT","DARP","IEIH","SYNB","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656304376","title":"Fresenius announces FDA approval of rituximab biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2656304376","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656304376?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:15","pubTimestamp":1785788150,"startTime":"0","endTime":"0","summary":"Fresenius Kabi, an operating company of Fresenius (FSNUY), announced that the U.S. Food and Drug Administration has approved a rituximab biosimilar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fresenius-announces-fda-approval-of-rituximab-biosimilar-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fresenius-announces-fda-approval-of-rituximab-biosimilar-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","LFSC","GNMX","IBB","TECB","PINK","PSCH","XLVX","SYNB","TBXU","BK4585","GDOC","MRNX","FRTY","BMED","NVIB","MRNY","IDNA","IYH","FSNUY","BK4196","IEIH","MEDI","LABU","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656334182","title":"Radiopharm Theranostics Seeks ASX Quotation for Major Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2656334182","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656334182?lang=en_us&edition=fundamental","pubTime":"2026-08-03 09:07","pubTimestamp":1785719235,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics Limited ( ($AU:RAD) ) has provided an update. Radiopharm Theranostics Limited operates in the medical and biotechnology sec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/radiopharm-theranostics-seeks-asx-quotation-for-major-share-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/radiopharm-theranostics-seeks-asx-quotation-for-major-share-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IBB","FWD","BK4588","IEIH","LNGR","AGNG","XT","SYNB","JDOC","BBP","RSPH","FHLC","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656618394","title":"Nanobiotix Updates Share Capital and Voting Rights as of June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2656618394","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656618394?lang=en_us&edition=fundamental","pubTime":"2026-08-01 05:27","pubTimestamp":1785533274,"startTime":"0","endTime":"0","summary":"Nanobiotix ( ($NBTX) ) has issued an announcement. Nanobiotix S.A., a Paris-based biotechnology company specializing in physics-driven nanotechnolo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-updates-share-capital-and-voting-rights-as-of-june-30-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-updates-share-capital-and-voting-rights-as-of-june-30-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","LNGR","BBP","IBB","RSPH","XT","BK4585","BK4588","FWD","JDOC","AGNG","FHLC","DARP","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655369759","title":"Fed officials warn not raising interest rates was a mistake","url":"https://stock-news.laohu8.com/highlight/detail?id=2655369759","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655369759?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:43","pubTimestamp":1785501833,"startTime":"0","endTime":"0","summary":"Inflation is a far more serious and persistent issue than the Fed has made it out to be, and it must be addressed by raising interest rates, a group of rate-setting committee members said Friday.For months, the war in Iran has destabilized the global energy market, pushing up gas prices in America. The Fed has no control over that, but that isn’t the only source of inflation pressures, the officials said.The Fed on Wednesday held interest rates steady for the fifth meeting in a row. However, three officials – Fed presidents Beth Hammack of Cleveland, Neel Kashkari of Minneapolis and Lorie Logan of Dallas – dissented in favor of raising rates by a quarter point. Two of them detailed their rationale for breaking ranks with the majority early Friday morning, with the third expected later today.Fed officials have kept their benchmark lending rate unchanged at a range of 3.5%-3.75% for all five policy meetings in 2026 so far.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cnn_highlight","url":"https://edition.cnn.com/2026/07/31/business/fed-interest-rates-dissents","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2026/07/31/business/fed-interest-rates-dissents","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["TYO","PBDC","ZROZ","GBIL","BIL","TBT","AGG","DBND","VCIT","KBE","MINT","TIP","VGSH","DFUV","BOXX","BSV","CLIX","IEI","SHY","FAZ","NGHT","UUP","SHV","AVSD","UDN","CGDV","BOND","VCSH","TLH","TMF","USHY","EDV","UBT","VGIT","BBP","VGLT","TBIL","ANEW","SKRE","CAOS","HYG","JPST","GOLY","MUB","TLTW","BND","SCHO","GOVT","LQD","FXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656646395","title":"Supply constraints, not falling interest rates, to drive property returns: Hines","url":"https://stock-news.laohu8.com/highlight/detail?id=2656646395","media":"Gerine Tang Yi Qian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656646395?lang=en_us&edition=fundamental","pubTime":"2026-07-31 06:24","pubTimestamp":1785450269,"startTime":"0","endTime":"0","summary":"Across real estate sectors, demand has been growing faster than new supply can be delivered, reads the firm's 2026 mid-year outlook. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/cityandcountry/property/supply-constraints-not-falling-interest-rates-drive-property-returns-hines?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/cityandcountry/property/supply-constraints-not-falling-interest-rates-drive-property-returns-hines?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["TSLP","TEST","07766","07366","TSLT","AVSD","BBP","TSII","FXL","TSLG","GLS.SI","REET","PEVC","TLA","CLR.SI","TSDD","09366","BK4585","TSLO","TSLZ","CAOS","CRSH","FXR","JJJ.SI","RJZ","SRU.SI","TSLI","CGDV","TSYY","VAW","09766","CFA.SI","IJK","KOMP","UCC","SRT.SI","LRCY","TESL","TSL","TSLQ","TSLW","TSLY","DFUV","RS1.SI","TSLR","TSLS","BK4588","ANEW","TSLL","CLIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655801296","title":"Biophytis Publishes 2025 Accounts as Trading Resumes Amid Going-Concern Doubts","url":"https://stock-news.laohu8.com/highlight/detail?id=2655801296","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655801296?lang=en_us&edition=fundamental","pubTime":"2026-07-30 23:59","pubTimestamp":1785427179,"startTime":"0","endTime":"0","summary":"Biophytis ( ($BPTSY) ) has provided an announcement. Biophytis SA, a Paris-based clinical-stage biotechnology group focused on age-related diseases...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biophytis-publishes-2025-accounts-as-trading-resumes-amid-going-concern-doubts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biophytis-publishes-2025-accounts-as-trading-resumes-amid-going-concern-doubts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","FHLC","BK4588","JDOC","AGNG","SYNB","LNGR","IBB","BBC","FWD","RSPH","BK4585","IEIH","XT","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655052148","title":"High interest rates and low confidence put construction firms under pressure, Lords warns","url":"https://stock-news.laohu8.com/highlight/detail?id=2655052148","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655052148?lang=en_us&edition=fundamental","pubTime":"2026-07-30 22:09","pubTimestamp":1785420540,"startTime":"0","endTime":"0","summary":"Lords Trading Group saw its stock slump on Thursday  Construction firms have been hit by a barrage of reduced market confidence, high interest rates and rising national insurance costs, builders’ merchant Lords has warned, after it suffered its biggest-ever single-day stock fall.The London-based firm released a challenging market update on Thursday, which saw its shares plunge 20.61 per cent to an all-time low of 13p. The stock is now down more than 40 per cent since the start of the year.Chief financial officer Stuart Kilpatrick said the primary driver of the slump was a lack of confidence from markets and individuals, which has left people “sitting on their hands a little bit.”He called on the government to streamline planning, restore stability and reduce financial pressures on business, including cutting employers’ national insurance.","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/07/Construction.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/07/Construction.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/high-interest-rates-and-low-confidence-put-construction-firms-under-pressure-lords-warns/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/high-interest-rates-and-low-confidence-put-construction-firms-under-pressure-lords-warns/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["ANEW","FXR","TLA","TSL","IJK","07766","CLIX","FXL","TSLP","TSLL","PEVC","TSDD","BK4585","TSII","KOMP","AVSD","BK4588","DFUV","RJZ","TESL","TSLS","TEST","BBP","TSLG","TSLQ","TSLZ","07366","VAW","09766","TSLI","TSLO","CGDV","TSLY","TSLT","TSLW","09366","LRCY","UCC","CAOS","TSYY","TSLR","CRSH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655287773","title":"BOE More Likely to Cut Rates than Raise Them","url":"https://stock-news.laohu8.com/highlight/detail?id=2655287773","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655287773?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:30","pubTimestamp":1785414600,"startTime":"0","endTime":"0","summary":"1230 GMT - Although the Bank of England continued to signal the possibility of raising interest rates Thursday, this looks unlikely, Capital Economics economist Paul Dales says. The BOE expects inflation to reach a peak of 3.2% in the fourth quarter before falling below 2.0% at the start of 2028. Capital Economics expects inflation to peak at 3.5% but sees it falling quicker to 2.0% by the end of 2027. \"That's why we don't think interest rates need to rise,\" Dales says. \"In fact, if we're right, interest rates may be cut to 3.00% in 2027.\" The BOE voted 6-3 to leave rates at 3.75%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07366","TSLY","TEST","CLIX","VAW","FXL","TSLQ","PEVC","TSLL","CRSH","07766","TSII","CAOS","FXR","09366","ANEW","CGDV","BK4585","BOE","TSL","TSLW","IJK","LRCY","RJZ","TSDD","TLA","TSLS","AVSD","TSLG","TSYY","KOMP","BBP","TSLR","TSLP","TESL","BK4588","DFUV","TSLT","UCC","TSLZ","TSLO","09766","TSLI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655879028","title":"Bank of England holds interest rates but warns of rises to come","url":"https://stock-news.laohu8.com/highlight/detail?id=2655879028","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655879028?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:04","pubTimestamp":1785409442,"startTime":"0","endTime":"0","summary":"The Bank of England has held interest rates. The Bank of England has opted to hold interest rates at 3.75 per cent after the UK economy surprised economists with better results for inflation – though policymakers warned that “policy strategy could change” ahead of a difficult second half of the year for price stability.The Monetary Policy Committee  held interest rates in a split 6-3 decision on Thursday, with the economist Catherine Mann joining fellow external member Megan Greene and the Bank’s chief economist Huw Pill in voting for a 25 basis point hike.Officials said recent data showing that inflation had eased to 2.6 per cent offered the Bank some relief and allowed the MPC to stick to current monetary policy.Minutes from the MPC’s latest meeting on setting interest rates said those voting for interest rates to be held believed “policy strategy could change” if inflation rose above expectations due to a re-escalation in conflict across the Middle East.","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/05/Bank-of-England-2025-e1779705509840.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/05/Bank-of-England-2025-e1779705509840.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bank-of-england-holds-interest-rates-at-3-75/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bank-of-england-holds-interest-rates-at-3-75/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["PRVS","CLIX","IDEV","TACN","MDLV","FXL","VAW","PEVC","HIDV","BKDV","IUS","CGUS","CDC","CAOS","FXR","ANEW","CGDV","FXD","FT","IMCG","LCG","ARP","BAMA","IJK","BSR","BBEU","MAPP","LRCY","RJZ","ADPV","FLGB","MPC","LGH","PSC","AVSD","MODL","DIVZ","KOMP","BBP","TSLP","REGL","FLV","CGUI","DFUV","ISVL","UCC","ILCV","EES","DECU","EQRR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655405608","title":"FTSE 100 Live: Stocks to fall after Trump warns Iran ‘beating’; Bank to hold interest rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2655405608","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655405608?lang=en_us&edition=fundamental","pubTime":"2026-07-30 13:30","pubTimestamp":1785389400,"startTime":"0","endTime":"0","summary":"Welcome back to City AM's FTSE 100 live blog Welcome back to theCity AMFTSE 100 liveblog.It’s Thursday morning and the Bank of England is expected to hold interest rates when its Monetary Policy Committee  announces its decision at 12pm today. Analysts across financial firms in the City are expecting the MPC to leave interest rates unchanged at 3.75 per cent. But the Bank could roll the pitch for a series of interest rate hikes this year after price shocks triggered by the war in Iran rippled through the global economy.The FTSE 100 is expected to fall this morning after hitting its highest-ever level on Wednesday. The blue-chip index rose to a record 10,951 in early trading. These gains then fell back slightly but it closed well above the red.UK investors brushed off the fresh flare-up in tensions between the US and Iran. President Trump told Fox News he would give Tehran “a beating” after it launched “surprise” attacks against US forces in the Middle East.Michael Dell, Lord Johnson an","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/07/Bank-of-England.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/07/Bank-of-England.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/ftse-100-live-stocks-to-fall-after-trump-warns-iran-beating-bank-to-hold-interest-rates/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/ftse-100-live-stocks-to-fall-after-trump-warns-iran-beating-bank-to-hold-interest-rates/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["FXR","TESL","TSYY","FTXN","TSLL","AVSD","IJK","GXPE","DRLL","KOMP","LRCY","TEST","IEO","TSLQ","CAOS","PEVC","TSLT","FKU","BBP","TSLW","TSLR","TSLZ","RSPG","RJZ","CRAK","CLIX","FLGB","DFUV","TSLS","ANEW","MPC","CGDV","TSLO","UCC","TSLI","TSDD","TSL","TSLP","PXI","PXE","TNGY","TLA","TSLG","09766","TSLY","CRSH","TRUN","TSII","FXL","VAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655812787","title":"JNJ enters strategic agreement to acquire Sail Biomedicines for $2.58B","url":"https://stock-news.laohu8.com/highlight/detail?id=2655812787","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655812787?lang=en_us&edition=fundamental","pubTime":"2026-07-30 05:35","pubTimestamp":1785360942,"startTime":"0","endTime":"0","summary":"Johnson & Johnson “announced strategic agreements and collaboration with Sail Biomedicines (Sail), a biotechnology company developing in vivo CAR-T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jnj-enters-strategic-agreement-to-acquire-sail-biomedicines-for-2-58b-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jnj-enters-strategic-agreement-to-acquire-sail-biomedicines-for-2-58b-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","LU0545562505.USD","JDOC","LU1221951129.SGD","FWD","SG9999001176.SGD","IXJ","LU1121112475.USD","IE00B1BXHZ80.USD","LU2213496289.HKD","LU2129689514.USD","LU1023059063.AUD","XT","AGNG","XLV","BBP","IBB","MEDX","GDOC","PJP","BK4550","LU0912757837.SGD","DARP","IYH","IE000MB6IJN5.SGD","LU1894683264.USD","CAR","LU2471134523.USD","FHLC","TRUH","LU1066051498.USD","IEIH","IHE","IE00B42XCP33.USD","RSPH","BK4581","LU2430703251.USD","LU0432979614.USD","FTXH","IE00BSNM7G36.USD","LNGR","SYNB","LU1066051811.HKD","JNJ","LU1430594728.SGD","RXL","VHT","LU1145028129.USD","IE00B4R5TH58.HKD","BK4230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655866896","title":"Alvotech announces successful closure of FDA inspection of manufacturing facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2655866896","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655866896?lang=en_us&edition=fundamental","pubTime":"2026-07-29 21:32","pubTimestamp":1785331920,"startTime":"0","endTime":"0","summary":"REYKJAVIK,ICELAND (July 29, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patien","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/29/3335332/0/en/Alvotech-announces-successful-closure-of-FDA-inspection-of-manufacturing-facility.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BBP","ALVO","IS","BK4585","BK4139","LABU","BK4097","EES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655895830","title":"Viatris receives FDA approval for Gwyn Lo contraceptive patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2655895830","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655895830?lang=en_us&edition=fundamental","pubTime":"2026-07-29 21:16","pubTimestamp":1785330964,"startTime":"0","endTime":"0","summary":"Viatris (VTRS) announced that the FDA has approved Gwyn Lo, a new combined hormonal contraceptive patch with low-dose estrogen. The patch has demon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viatris-receives-fda-approval-for-gwyn-lo-contraceptive-patch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viatris-receives-fda-approval-for-gwyn-lo-contraceptive-patch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","TECB","FRTY","MRNX","LU2087621335.USD","IBB","MEDI","VTRS","IDNA","NVIB","TBXU","PINK","BK4583","BMED","BK4007","GNMX","GDOC","SYNB","BBP","BK4588","LABU","LFSC","IYH","LU1839511570.USD","RSPH","BK4585","PSCH","IEIH","XLVX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}